GATTUSO, IRENE
GATTUSO, IRENE
Facoltà di Medicina e Chirurgia
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series
2024-01-01 Guerrieri, S.; Rubin, M.; Gattuso, I.; Zanetta, C.; Genchi, A.; Preziosa, P.; Rocca, M. A.; Filippi, M.; Moiola, L.
Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study
2025-01-01 Zaccone, T.; Moiola, L.; Guerrieri, S.; Nozzolillo, A.; Zanetta, C.; Gattuso, I.; Genchi, A.; Esposito, F.; Scarale, M. G.; Rancoita, P. M. V.; Rocca, M. A.; Filippi, M.
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience
2023-01-01 Guerrieri, Simone; Bucca, Chiara; Nozzolillo, Agostino; Genchi, Angela; Zanetta, Chiara; Cetta, Ilaria; Rugarli, Giulia; Gattuso, Irene; Azzimonti, Matteo; Rocca, Maria Assunta; SanRaf MS Study, Group; Preziosa, Paolo; Paolo, Moiola; Lucia, ; Filippi, Massimo
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab
2025-01-01 Moiola, L.; Mandelli, A.; Tarkowski, M.; Finardi, A.; Gabrieli, A.; Zanetta, C.; Viti, V.; Gattuso, I.; Esposito, F.; Pedotti, R.; Muros-Le Rouzic, E.; Raposo, C.; Rocca, M. A.; Locatelli, M.; Bonini, C.; Furlan, R.; Riva, A.; Filippi, M.
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis
2025-01-01 Giordano, A.; Giliberti, A.; Clarelli, F.; Misra, K.; Mascia, E.; Sorosina, M.; Visentin, G.; Margoni, M.; Moiola, L.; Rocca, M. A.; Filippi, M.; Esposito, F.; Azzimonti, M.; Colombo, B.; D'Amore, G.; Ferre, L.; Genchi, A.; Guerrieri, S.; Gueye, M.; Gattuso, I.; Preziosa, P.; Rubin, M.; Visentin, G.; Viti, V.; Zaccone, T.; Zanetta, C.
Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use
2025-01-01 Guerrieri, Simone; Gattuso, Irene; Genchi, Angela; Nozzolillo, Agostino; Viti, Vittorio; Zanetta, Chiara; D'Amore, Giulia; Rocca, Maria A.; Moiola, Lucia; Filippi, Massimo
Unveiling a silent threat: slowly expanding spinal cord lesion linked to clinical worsening in multiple sclerosis: a case report
2025-01-01 Martire, Maria Sofia; Gattuso, Irene; Vezzulli, Paolo; Guerrieri, Simone; Falini, Andrea; Moiola, Lucia; Genchi, Angela; Filippi, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series | 1-gen-2024 | Guerrieri, S.; Rubin, M.; Gattuso, I.; Zanetta, C.; Genchi, A.; Preziosa, P.; Rocca, M. A.; Filippi, M.; Moiola, L. | |
| Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study | 1-gen-2025 | Zaccone, T.; Moiola, L.; Guerrieri, S.; Nozzolillo, A.; Zanetta, C.; Gattuso, I.; Genchi, A.; Esposito, F.; Scarale, M. G.; Rancoita, P. M. V.; Rocca, M. A.; Filippi, M. | |
| Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience | 1-gen-2023 | Guerrieri, Simone; Bucca, Chiara; Nozzolillo, Agostino; Genchi, Angela; Zanetta, Chiara; Cetta, Ilaria; Rugarli, Giulia; Gattuso, Irene; Azzimonti, Matteo; Rocca, Maria Assunta; SanRaf MS Study, Group; Preziosa, Paolo; Paolo, Moiola; Lucia, ; Filippi, Massimo | |
| Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab | 1-gen-2025 | Moiola, L.; Mandelli, A.; Tarkowski, M.; Finardi, A.; Gabrieli, A.; Zanetta, C.; Viti, V.; Gattuso, I.; Esposito, F.; Pedotti, R.; Muros-Le Rouzic, E.; Raposo, C.; Rocca, M. A.; Locatelli, M.; Bonini, C.; Furlan, R.; Riva, A.; Filippi, M. | |
| Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis | 1-gen-2025 | Giordano, A.; Giliberti, A.; Clarelli, F.; Misra, K.; Mascia, E.; Sorosina, M.; Visentin, G.; Margoni, M.; Moiola, L.; Rocca, M. A.; Filippi, M.; Esposito, F.; Azzimonti, M.; Colombo, B.; D'Amore, G.; Ferre, L.; Genchi, A.; Guerrieri, S.; Gueye, M.; Gattuso, I.; Preziosa, P.; Rubin, M.; Visentin, G.; Viti, V.; Zaccone, T.; Zanetta, C. | |
| Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use | 1-gen-2025 | Guerrieri, Simone; Gattuso, Irene; Genchi, Angela; Nozzolillo, Agostino; Viti, Vittorio; Zanetta, Chiara; D'Amore, Giulia; Rocca, Maria A.; Moiola, Lucia; Filippi, Massimo | |
| Unveiling a silent threat: slowly expanding spinal cord lesion linked to clinical worsening in multiple sclerosis: a case report | 1-gen-2025 | Martire, Maria Sofia; Gattuso, Irene; Vezzulli, Paolo; Guerrieri, Simone; Falini, Andrea; Moiola, Lucia; Genchi, Angela; Filippi, Massimo |